Medical Center Kalimat
About Medical Center Kalimat
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Amgen
2
Bayer
1
Kowa Research Institute, Inc.
1
Clinical Trials at Medical Center Kalimat
During the past decade, Medical Center Kalimat conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
2017-03-23
2022-07-27
Terminated
10,544
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
2019-06-11
2025-07-26
Active, not recruiting
12,301
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
2020-10-20
2025-06-25
Recruiting
678
A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)
2022-04-19
2024-01-05
Recruiting
40,000
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Center Kalimat"
#1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Medical Center Kalimat
According to Clinical.Site data, the most researched conditions in "Medical Center Kalimat" are
"Atherosclerotic Cardiovascular Disease" (1 trials), "Cancer" (1 trials), "Coronary Heart Disease (CHD)" (1 trials), "Dyslipidemia" (1 trials) and "Type2 Diabetes" (1 trials). Many other conditions were trialed in "Medical Center Kalimat" in a lesser frequency.
Clinical Trials Intervention Types at Medical Center Kalimat
Most popular intervention types in "Medical Center Kalimat" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Darolutamide (Nubeqa, BAY1841788)" (1 trials), "Evolocumab" (1 trials), "K-877" (1 trials) and "Lp(a) Screening" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Medical Center Kalimat
The vast majority of trials in "Medical Center Kalimat" are
3 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Medical Center Kalimat
Currently, there are NaN active trials in "Medical Center Kalimat".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Medical Center Kalimat,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Medical Center Kalimat, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".